Hideho Okada

17.3k total citations · 2 hit papers
198 papers, 8.8k citations indexed

About

Hideho Okada is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Hideho Okada has authored 198 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Immunology, 113 papers in Oncology and 58 papers in Molecular Biology. Recurrent topics in Hideho Okada's work include Immunotherapy and Immune Responses (101 papers), CAR-T cell therapy research (74 papers) and Glioma Diagnosis and Treatment (55 papers). Hideho Okada is often cited by papers focused on Immunotherapy and Immune Responses (101 papers), CAR-T cell therapy research (74 papers) and Glioma Diagnosis and Treatment (55 papers). Hideho Okada collaborates with scholars based in United States, Japan and Switzerland. Hideho Okada's co-authors include Gary Kohanbash, Ian F. Pollack, Mitsugu Fujita, Ronald L. Hamilton, Xinmei Zhu, Walter J. Storkus, Ryo Ueda, William H. Chambers, Theresa L. Whiteside and Michael T. Lotze and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Hideho Okada

194 papers receiving 8.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group

2015 471 citations Hideho Okada, Ian F. Pollack et al. profile →
Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment

2017 434 citations Gary Kohanbash, Payal Watchmaker et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Hideho Okada	5.1k	4.1k	2.8k	2.6k	1.1k	198	8.8k
Gary E. Archer	3.2k 0.6×	3.7k 0.9×	1.8k 0.7×	2.4k 0.9×	484 0.4×	80	6.5k
Robert M. Prins	3.1k 0.6×	3.0k 0.7×	3.5k 1.3×	3.0k 1.1×	2.2k 2.1×	140	8.7k
Ravindra Majeti	7.4k 1.4×	3.9k 0.9×	8.0k 2.9×	1.5k 0.6×	2.0k 1.8×	161	16.4k
Peter E. Fecci	2.2k 0.4×	2.4k 0.6×	1.1k 0.4×	2.1k 0.8×	348 0.3×	150	5.2k
Jörg Wischhusen	2.3k 0.4×	2.6k 0.6×	2.7k 1.0×	1.4k 0.5×	1.4k 1.3×	91	6.7k
Mark S. Cragg	4.0k 0.8×	3.0k 0.7×	3.8k 1.4×	1.8k 0.7×	637 0.6×	198	10.2k
Katrin Lamszus	1.0k 0.2×	2.2k 0.5×	3.8k 1.4×	2.5k 1.0×	2.1k 2.0×	154	7.8k
Leila Akkari	3.3k 0.6×	1.8k 0.4×	1.9k 0.7×	1.0k 0.4×	930 0.9×	45	5.6k
Hiroaki Wakimoto	1.3k 0.3×	3.8k 0.9×	4.8k 1.7×	2.3k 0.9×	1.5k 1.4×	185	9.4k
Christine E. Brown	2.6k 0.5×	5.6k 1.4×	3.6k 1.3×	996 0.4×	429 0.4×	176	9.5k

Countries citing papers authored by Hideho Okada

Since Specialization

Citations

This map shows the geographic impact of Hideho Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideho Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideho Okada more than expected).

Fields of papers citing papers by Hideho Okada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideho Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideho Okada. The network helps show where Hideho Okada may publish in the future.

Co-authorship network of co-authors of Hideho Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Hideho Okada. A scholar is included among the top collaborators of Hideho Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideho Okada. Hideho Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Yutong, C.-S. Park, Akane Yamamichi, et al.. (2024). Ultrasound frequency-controlled microbubble dynamics in brain vessels regulate the enrichment of inflammatory pathways in the blood-brain barrier. Nature Communications. 15(1). 8021–8021. 18 indexed citations

Simic, Milos, Payal Watchmaker, Haoyu Long, et al.. (2024). DIPG-15. NOVEL CNS SENSING SYNNOTCH-CAR T CELLS FOR TARGETING DIFFUSE MIDLINE GLIOMA. Neuro-Oncology. 26(Supplement_4). 0–0. 1 indexed citations

Okada, Hideho, et al.. (2024). Activating the dark genome to illuminate cancer vaccine targets. Nature Genetics. 56(9). 1770–1771. 2 indexed citations

Hou, Andrew J., Benjamin R. Uy, Begonya Comin-Anduix, et al.. (2024). IL-13Rα2/TGF-β bispecific CAR-T cells counter TGF-β-mediated immune suppression and potentiate anti-tumor responses in glioblastoma. Neuro-Oncology. 26(10). 1850–1866. 32 indexed citations

Gibson, David R., Eduardo A. Rodríguez, Susan M. Chang, et al.. (2023). Quantitative analysis of MGMT promoter methylation in glioblastoma suggests nonlinear prognostic effect. Neuro-Oncology Advances. 5(1). vdad115–vdad115. 6 indexed citations

Gallus, Marco, et al.. (2023). Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma. Cancers. 15(14). 3726–3726. 11 indexed citations

Hwang, Eugene, Elias Sayour, Catherine Flores, et al.. (2022). The current landscape of immunotherapy for pediatric brain tumors. Nature Cancer. 3(1). 11–24. 34 indexed citations

Chuntova, Pavlina, Yafei Hou, Akane Yamamichi, et al.. (2021). Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice. Neuro-Oncology. 24(2). 259–272. 11 indexed citations

Chapelin, Fanny, Benjamin I. Leach, Ruifeng Chen, et al.. (2021). Assessing Oximetry Response to Chimeric Antigen Receptor T-cell Therapy against Glioma with ¹⁹F MRI in a Murine Model. Radiology Imaging Cancer. 3(1). e200062–e200062. 9 indexed citations

10.

Pinton, Laura, Elena Masetto, Samantha Solito, et al.. (2019). The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion. Journal for ImmunoTherapy of Cancer. 7(1). 58–58. 116 indexed citations

11.

Okada, Hideho, Lisa H. Butterfield, Ronald L. Hamilton, et al.. (2014). Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC. Clinical Cancer Research. 21(2). 286–294. 83 indexed citations

12.

Ohkuri, Takayuki, Arundhati Ghosh, Akemi Kosaka, et al.. (2014). STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment. Cancer Immunology Research. 2(12). 1199–1208. 196 indexed citations

13.

Yeung, Jacky T., Ronald L. Hamilton, Koji Ohnishi, et al.. (2013). LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma. Clinical Cancer Research. 19(7). 1816–1826. 71 indexed citations

14.

Kohanbash, Gary, Masashi Sakaki, Ryo Ueda, et al.. (2013). GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-α. Cancer Research. 73(21). 6413–6423. 134 indexed citations

15.

Fujita, Mitsugu, Gary Kohanbash, Wendy Fellows-Mayle, et al.. (2011). COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells. Cancer Research. 71(7). 2664–2674. 315 indexed citations

16.

Fujita, Mitsugu, Michael E. Scheurer, Stacy A. Decker, et al.. (2010). Role of Type 1 IFNs in Antiglioma Immunosurveillance—Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans. Clinical Cancer Research. 16(13). 3409–3419. 76 indexed citations

17.

Ueda, Ryo, Mitsugu Fujita, Xinmei Zhu, et al.. (2009). Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines. Clinical Cancer Research. 15(21). 6551–6559. 94 indexed citations

18.

Fujita, Mitsugu, Xinmei Zhu, Ryo Ueda, et al.. (2009). Effective Immunotherapy against Murine Gliomas Using Type 1 Polarizing Dendritic Cells—Significant Roles of CXCL10. Cancer Research. 69(4). 1587–1595. 84 indexed citations

19.

Sasaki, Kotaro, Xinmei Zhu, Fumihiko Nishimura, et al.. (2007). Preferential Expression of Very Late Antigen-4 on Type 1 CTL Cells Plays a Critical Role in Trafficking into Central Nervous System Tumors. Cancer Research. 67(13). 6451–6458. 49 indexed citations

20.

Nishimura, Fumihiko, Jill E. Dusak, Junichi Eguchi, et al.. (2006). Adoptive Transfer of Type 1 CTL Mediates Effective Anti–Central Nervous System Tumor Response: Critical Roles of IFN-Inducible Protein-10. Cancer Research. 66(8). 4478–4487. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact